Relationship Between Fecal Calprotectin and Upper Endoscopy Findings in Children With Upper Gastrointestinal Symptoms

Background: Chronic abdominal pain in children is a common disorder. For an accurate diagnosis of its cause, sometimes invasive diagnostic procedures such as endoscopy should be performed. Objectives: The purpose of the study was to evaluate the fecal calprotectin in children with upper gastrointestinal signs and symptoms and to compare it with endoscopic findings. Methods: A total of 131 children aged 1-14 years with upper gastrointestinal symptoms were enrolled during 2012 - 2013 at two centers. One hundred and twenty patients underwent endoscopy and biopsy. Before endoscopy, the level of calprotectin was measured by the enzyme-linked immunosorbent assay test in stool samples and the results were compared with the endoscopic and pathology findings. Results: Of the 120 children included in this study, 71 (59.2%) were males and 49 (40.8%) females with a mean age of 93.6 months. Of the 112 patients in whom biopsies were taken, 16 had esophagitis, 89 chronic gastritis (79.5%) and 57 colonization with Helicobacter pylori. Conclusions: There was a statistically significant correlation between fecal calprotectin and gastritis and severity of H. pylori infection. Fecal calprotectin level measurement can avoid unnecessary endoscopies and is also useful for evaluation of therapy response.

[1]  F. Vernuccio,et al.  Functional and organic abdominal pain: Role of fecal calprotectin and common serum markers in the differential diagnosis , 2013 .

[2]  A. Gasbarrini,et al.  Role of fecal calprotectin in gastrointestinal disorders. , 2013, European review for medical and pharmacological sciences.

[3]  C. Beglinger,et al.  Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study , 2012, BMC Gastroenterology.

[4]  A. Gasbarrini,et al.  Can chronic gastritis cause an increase in fecal calprotectin concentrations? , 2010, World journal of gastroenterology.

[5]  A. Elbadry,et al.  Faecal calprotectin in differentiating between functional and organic bowel diseases , 2010 .

[6]  J. Passchier,et al.  Prognosis of Chronic or Recurrent Abdominal Pain in Children , 2008, Journal of pediatric gastroenterology and nutrition.

[7]  A. Firmansyah,et al.  Natural Evolution of Infantile Regurgitation Versus the Efficacy of Thickened Formula , 2008, Journal of pediatric gastroenterology and nutrition.

[8]  A. Day,et al.  Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children , 2008, Inflammatory bowel diseases.

[9]  L. Hansson,et al.  Fecal Calprotectin: A Quantitative Marker of Colonic Inflammation in Children With Inflammatory Bowel Disease , 2007, Journal of pediatric gastroenterology and nutrition.

[10]  A. Poullis,et al.  Emerging role of calprotectin in gastroenterology , 2003, Journal of gastroenterology and hepatology.